Recruiting
Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver Issues
additive efficacy of physical activity program in hypthyroidism in elder females with glaucoma and fatty liver issues was not investigated
ClinicalTrials.gov IDNCT07599241
PhaseNA
Enrollment40
SponsorCairo University
Age65 Years – 75 Years
SexFEMALE
Conditions studied
Subclinical hypothyroïdism, Non-Alcoholic Fatty Liver Disease, Primary Open Angle Glaucoma
About this study
additive efficacy of physical activity program in hypthyroidism in elder females with glaucoma and fatty liver issues was not investigated
Interventions
- Behavioral: physical activity — hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine and physical activity program on treadmill thrice weehly for 6 month
- Other: usual care — hypthyroidism elder females (n=20) with glaucoma and fatty liver issues that will recive their levothyroxine only
Primary outcomes
- intraocular pressure (6 months)
Eligibility information
Inclusion Criteria:
* subclinical hypothrodism (significant form)
* primary opened angle gaulcoma in both eyes with ocular hypertension in both eyes )(high-tension typed glaucoma)
* fatty liver (non alcholic type)
* elder females
Exclusion Criteria:
* respiratory issues
* cardiac issues
* renal issues
Study locations
- Cairo University, Dokki, Giza Governorate 11432 Egypt
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-04.